TWD 84.2
(-0.24%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -1 Billion TWD | -125.21% |
2022 | -437.72 Million TWD | 16.99% |
2021 | -527.31 Million TWD | -9.44% |
2020 | -481.81 Million TWD | -2.49% |
2019 | -470.12 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -106.45 Million TWD | 67.7% |
2024 Q2 | -151.5 Million TWD | -54.36% |
2023 Q4 | -329.55 Million TWD | -53.34% |
2023 FY | -985.78 Million TWD | -125.21% |
2023 Q3 | -214.91 Million TWD | 20.0% |
2023 Q2 | -268.65 Million TWD | -55.6% |
2023 Q1 | -172.65 Million TWD | 76.49% |
2022 FY | -437.72 Million TWD | 16.99% |
2022 Q4 | -734.52 Million TWD | 0.0% |
2021 FY | -527.31 Million TWD | -9.44% |
2020 FY | -481.81 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | 1235.814% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | 756.156% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | -519.171% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 173.419% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 263.91% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | 1291.695% |
Center Laboratories, Inc. | -79.26 Million TWD | -1171.212% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | 5030.642% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | 3730.692% |
InnoPharmax Inc. | -64.83 Million TWD | -1454.043% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | 1054.453% |
Excelsior Biopharma Inc. | -81.12 Million TWD | -1142.02% |
DV Biomed Co., Ltd. | 173.54 Million TWD | 680.6% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 244.817% |
UniPharma Co., Ltd. | -27.3 Million TWD | -3590.262% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | 1995.709% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 361.363% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | 613.83% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | -2105.353% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | -5112.488% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | 1683.571% |